|
||||||
| Home |
| Find a Clinical Trial |
| Clinical Trial FAQs |
| About Informed Consent |
| Clinical Trials Glossary |
| Medical Research Areas |
| Clinical Trial Resources |
|
 |
Sign up and receive information about Novartis clinical trials in your health-related areas of interest. For U.S. residents only. | |
|
|
 |
|
|
|
|||
|
Novartis Clinical
Trials provides information about research studies recruiting
within the U.S. Visit ClinicalTrials.gov, a registry of federally and privately supported clinical trial for more information regarding clinical trials outside of the U.S. |
|
|
Arthritis and Rheumatology Clinical Trials
About Arthritis, Rheumatology and Bone HealthThe Primary disease focus is rheumatoid arthritis, osteoarthritis and osteoporosis. Researchers also capitalize on scientific opportunities that emerge from primary research focus, including the development of novel therapies for tumor-induced hypercalcaemia and fracture repair. Some research may also provide benefit in other inflammatory conditions such as asthma, dermatitis and autoimmune diseases. Arthritis, Rheumatology and Bone Health Clinical Trials at NovartisAt Novartis, new medications are being developed to treat the symptoms and the underlying causes of several of the main conditions affecting bones and joints. Currently, Novartis is exploring a number of novel compounds via arthritis and rheumatology clinical trials that may apply to some of the following conditions listed below. OsteoporosisOne in two women and one in eight men over 50 will have an osteoporosis-related fracture in their lifetime. Different approaches are available to increase the rate of new bone formation and slowing the rate of its removal. Newer medications are being investigated. OsteoarthritisThis common degenerative joint disease is an expression of 'wear-and-tear'. Thus athletes or overweight people develop osteoarthritis in large joints (knees, shoulders, hips) due to loss or damage of cartilage. When cartilage is lost, the bone next to the joint is also eroded. New medications are being investigated. Rheumatoid arthritisIn this chronic disease various joints in the body are inflamed, leading to swelling, pain, stiffness, and possibly loss of function. Continuous inflammation gradually erodes the joint cartilage, narrows the joint space and eventually damages bone. The inflammatory process not only affects the joints but can also harm organs in other parts of the body. If you are interested in learning more about other disease areas or therapeutic areas of Novartis clinical research, please select from the list below.
|